## 



## 

## 

## 

|CONTENTS|||PAGES|
|---|---|---|---|
|Members ofthe Board and professional|advisers|||
|Trustees Annual Report|||2to 8|
|Independent<br>auditor's<br>report to the members|||9to 12|
|Statement offinancial<br>activities (incorporating||the||
|income and expenditure<br>account)|||13|
|Balance sheets|||14to 15|
|Statement ofCash Flows|||16|
|Notes to the financial<br>statements|||17to 26|





## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 

|||||Unrestricted|Restricted|Total Funds|Total Funds|
|---|---|---|---|---|---|---|---|
|||||Funds|Funds|2021|2020|
||||Note|||||
|INCOME AND||||||||
|ENDOWMENTS||||||||
|Charitable<br>activities||||63&568||63,568|53,923|
|Donations<br>and legacies<br>Other income||||1,406,134<br>20,093||1,406,134<br>20,093|697,108<br>9,279|
|Other trading activities:<br>Nova Health Clinic limited||||11,583||11,583|4,144|
|TOTAL INCOME||||1&501,378||1&501,378|764,454|
|EXPENDITURE||||||||
|Expenditure<br>on charitable<br>activities|||7/8|(846,119)|(8,163)|(854,282)|(619,383)|
|Expenditure<br>on raising||funds:||||||
|Costs ofraising donations<br>and legacies<br>Nova Health Clinic limited|||9<br>10|(198,419)<br>(99,026)||(198,419)<br>(99,026)|(68,300)<br>(78,741)|
|Other Expenditure||||(6,058)||(6&058)||
|TOTAL||||(1&149,622)|(8,163)|(1,157,785)|(766,424)|
|NET INCOME||||351,756|(8,163)|343,593|(1,970)|
|RECONCILIATION||OF||||||
|FUNDS||||||||
|Total funds brought|forward|||27,518|73,474|100,992|102,962|
|TOTAL FUNDS CARRIED||||||||
|FORWARD||||379,274|65&311|444,585|100,992|





## 

## 

## 

||30JUNE 2|021|||||
|---|---|---|---|---|---|---|
|||||2021||2020|
|||Note|||||
|FIXEDASSETS|||||||
|Tangible fixed assets||16|||127,396|123,913|
|CURRENT ASSETS|||||||
|Debtors||18||1,000||1,000|
|Cash at bank and in hand||||395,373||72,309|
|||||396,373||73,309|
|CREDITORS: amounts|falling due within one||||||
|year||19||30&015||46,230|
|NKT CURRENT ASSETS|||||366,358|27,079|
|TOTAL ASSETSLESS|CURRENT LIABILITIES||||493,754|150,992|
|CREDITORS: amounts|falling due after more||||||
|than one year||20|||49169|50000|
|NKT ASSETS|||||444,585|100,992|
|FUNDS OFTHK CHARITY|||||||
|Restricted funds|||22||65,311|73,474|
|Unrestricted<br>funds|||23||379,274|27,518|
|TOTAL CHARITY FUNDS|||||444,585|100,992|





## 

## 

||||||2021||2020|
|---|---|---|---|---|---|---|---|
||||Note|||||
|FIXEDASSETS||||||||
|Tangible fixed assets<br>Investments|||16<br>17|||127,396<br>100|123,913<br>100|
|||||||127,496|124,013|
|CURRENT ASSETS||||||||
|Debtors|||18||5,064||1,000|
|Cash at bank and in hand|||||388,609||70,613|
||||||393,673||71,613|
|CREDITORS: amounts|falling due within|one||||||
|year|||19||27,415||44,670|
|NKT CURRENT ASSETS||||||366,258|26,943|
|TOTAL ASSETSLESS|CURRENT LIABILITIES|||||493,754|150,956|
|CREDITORS: amounts<br>than one year|falling due after|more|20|||49,169|50,000|
|NET ASSETS||||||444,585|100,956|
|FUNDS OF THE CHARITY||||||||
|Restricted funds||||22||65,311|73,474|
|Unrestricted<br>funds||||23||379,274|27,482|
|TOTAL CHARITY FUNDS||||||444,585|100,956|





## 

## 

||2021|2020|
|---|---|---|
|||f|
|CASH FLOWS FROM OPERATING ACTIVITIES|||
|Net income|343,593|(1,970)|
|Adjustments for:<br>Depreciation oftangible fixed assets<br>Interest payable<br>and similar charges|18,674<br>105|15,223<br>1,423|
|Changes in:<br>Trade and other debtors||(1,000)|
|Trade and other creditors|(16,215)|(13,547)|
|Cash generated<br>from operations|346,157|129|
|Interest received|(105)|(1,423)|
|Net cash from operating<br>activities|346,052|(1,294)|
|CASH FLOWS FROM INVESTING ACTIVITIES|||
|Purchase oftangible<br>assets|(22,157)|(8,609)|
|Net cash used in investing<br>activities|(22,157)|(8,609)|
|CASH FLOWS FROM FINANCING ACTIVITIES|||
|Proceeds from borrowing|(831)|50,000|
|Net cash from financing<br>activities|(831)|50,000|
|NET INCREASE / (DECREASE) IN CASH AND<br>CASH EQUIVALENTS<br>CASH AND CASH EQUIVALENTS AT BEGINNING OFYEAR|323,064<br>72,309|40,097<br>32,212|
|CASH AND CASH EQUIVALENTS AT END OFYEAR|395,373|72,309|





## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

|4.|INCOME FR|OM CHARITABLE ACTIV|ITIES|||
|---|---|---|---|---|---|
||||||Total Funds|
||||Unrestricted|Total Funds|Unrestricted|
||||Funds|2021|2020|
||||K|||
||Patient contributions||63,568|63,568|53,923|
|5.|DONATIONS|AND LEGACIES||||
||||Unrestricted|Restricted|Total Funds|
||||Funds|Funds|2021|
||Donations|||||
||Donations||1,376,134||1,376,134|
||Grants|||||
||Legacies<br>Legacies||30,000||30,000|
||||1,406, 134||1,406,134|
||||Unrestricted|Restricted|Total Funds|
||||Funds|Funds|2020|
||Donations|||||
||Donations||637,108|50,000|687,108|
||Grants||10,000||10,000|
||Legacies|||||
||Legacies|||||
||||647,108|50,000|697,108|





## 

## 

## 

|6.|OTHER TRADIN|G ACTIV|ITIES||||
|---|---|---|---|---|---|---|
|||||||Total Funds|
|||||Unrestricted|Total Funds|Unrestricted|
|||||Funds|2021|2020|
||||||5||
||Nova Health Clinic|income||11,583|11,583|4,144|
|7.|COSTS OF CHARITABLE||ACTIVITIES BYFUND TYPE||||
||||Unrestricted|Restricted|Total Funds|Total Funds|
||||Funds|Funds|2021|2020|
|||||t.|||
||Patient advice||235,569||235,569|202,868|
||Patient advocacy<br>Medical treatment|costs|16,595<br>514,266||16,595<br>516,211|11,646<br>375,460|
||Nova Health Clinic (note 1)<br>Support costs||1,704<br>77,985|8,163|7,922<br>77,985|8,869<br>20,540|
||||846,119|8,163|854,282|619,383|



|COSTS OF|CHAR|ITABLE A|CTIVITIES BYACTI|VITY TYPE|||
|---|---|---|---|---|---|---|
||||Activities||||
||||undertaken|Support|Total Funds|Total Funds|
||||directly|costs|2021|2020|
|||||K|||
|Patient advice|||235,569|18,256|253,825|212,648|
|Patient advocacy<br>Medical treatment||costs|16,595<br>514&266|1,286<br>39,854|17,881<br>554,120|11,646<br>375,460|
|Nova Health|Clinic||9,867|765|10,632|8,869|
|Governance|costs|||17,824|17,824|10,760|
||||776,297|77,985|854,282|619,383|





## 

## 

## 

||||||Total Funds|
|---|---|---|---|---|---|
||||Unrestricted|Total Funds|Unrestricted|
||||Funds|2021|2020|
||Fundraising<br>costs||198&419|198,419|68,300|
|10.|COSTS OFOTHER TRADING ACTIVITES|||||
||||||Total Funds|
||||Unrestricted|Total Funds|Unrestricted|
||||Funds|2021|2020|
||Nova Health Clinic costs||99,026|99,026|78,741|
|11.|NET INCOME FOR THE YEAR|||||
||This is stated after charging:|||2021|2020|
||||||t|
||Depreciation oftangible fixed assets (note <br>Foreign exchange differences|16)||18,674<br>139|15,223<br>191|
|12.|AUDITORS REMUNERATION|||||
|||||2021|2020|
||Fees payable for the audit ofthe financial|statements||9,000||
|13.|INDEPENDENT EXAMINATION FEES|||||
|||||2021|2020|
||Fees payable to the independent<br>examiner <br>Independent<br>examination<br>ofthe financial|for:<br> statements|||7,200|
|14.|STAFF COSTS AND EMOLUMENTS|||||
||Total staff costs were as follows:|||||
|||||2021|2020|
|||||K||
||Wages and salaries<br>Social security costs<br>Employer<br>contributions<br>to pension plans|||94,178<br>8,910<br>226|79397<br>6,889|
|||||83,918|82,907|





## 

## 

|culars|ofemployees:|||
|---|---|---|---|
|||2021|2020|
|||No|No|
|Number|ofFull Time Staff|1|1|
|Number|ofPart Time Staff|3|3|
|||4|4|



|The number ofemployees|whose remuneration|for the year fell within the following bands, were:|for the year fell within the following bands, were:|
|---|---|---|---|
|||2021|2020|
|||No|No|
|660000to669999||1||



## 

## 

## 

## 

## 

|Group and company|||||||
|---|---|---|---|---|---|---|
||Short||||||
||leasehold|Plant and|||||
||improvements|machinery|Equipment|Sefer|Torah|Total|
||6||0||6||
|Cost|||||||
|At 1 July 2020<br>Additions|64,509|1,813|97,766<br>11,077||11,080|164,088<br>22,157|
|At 30June 2021|64,509|1,813|108,843||11,080|186,245|
|Depreciation<br>At 1 July 2020<br>Charge for the year|15,696<br>6,380|1,048<br>191|23,431<br>12,103|||40,175<br>18,674|
|At 30June 2021|22,076|1,239|35,534|||58,849|
|Carrying<br>amount<br>At 30June 2021|42,433|574|73,309||11,080|127,396|
|At 30June 2020|48,813|765|74,335|||123,913|
|INVESTMKNTS|||||||
|Movement<br>in market value|||||||
|||||2021||2020|
|||||g|||
|Market value at 1 July 2020|||||100|100|
|Market value at 30June 2021|||||100|100|
|Historical cost at 30June 2021|||||100|100|





## 

## 

|Analysis ofinvestments<br>at|30June 2021 betwe|en funds|||
|---|---|---|---|---|
||Unrestricted|Restricted|Total Funds|Total Funds|
||Funds|Funds|2021|2020|
|Other investments|||||
|UK Group undertakings|100||100|100|



## 

|||Group||Company||
|---|---|---|---|---|---|
|||2021|2020|2021|2020|
|||X||||
|Amounts<br>owed by group undertakings<br>Other debtors||1,000|1,000|4,064<br>1,000|1,000|
|||1,000|1,000|5,064|1,000|



## 

|See note 26for related party transaction<br>CREDITORS: Amounts<br>falling due|s<br>included<br>in other <br> within one year|debtors.|||
|---|---|---|---|---|
||Group||Company||
||2021|2020|2021|2020|
||s||||
|Social security and other taxes<br>Accruals and deferred income|6,415<br>9,000|1,470<br>7,200|6,415<br>9,000|1,470<br>7,200|
|Other creditors|14,600|37,560|12,000|36,000|
||30,015|46,230|27,415|44,670|



## 

|2021|2020|
|---|---|
|49,169|50,000|



## 

## 



## 

## 

## 

## 

|RESTRICTED INCO|ME FUNDS|||||
|---|---|---|---|---|---|
|Group and Company||||||
||Balance at<br>1July 2020|Incoming<br>resources<br>K|Outgoing<br>resources|Transfers|Balance at<br>30June 2021<br>8|
|Restricted Fund|73,474||($,163)||65,311|
||Balance at|Incoming|Outgoing||Balance at|
||1 July 2019|resources|resources|Transfers|31 June 2020|
|Restricted Fund|81,637|50,000|(8,163)|(50,000)|73,474|
|UNRESTRICTED INCOME FUNDS||||||
|Group||||||
||Balance at<br>1July 2020|Incoming<br>resources|Outgoing<br>resources|Transfers|Balance at<br>30June 2021|
||||8|K||
|General Funds|27,518|1,501,378|(1,149,622)||379,274|
||Balance at|Incoming|Outgoing||Balance at|
||1 July 2019|resources|resources|Transfers|30June 2020|
|General Funds|21,325|714,454|(758,261)|50,000|27,518|
|Company||||||
||Balance at<br>1July 2020|Incoming<br>resources|Outgoing<br>resources|Transfers|Balance at<br>30June 2021|
|||8|||K|
|General Funds|27,4$2|1,489,795|(1,138,003)||379,274|
||Balance at|Incoming|Outgoing||Balance at|
||1 July 2019|resources|resources|Transfers|30June 2020|
|General Funds|18,543|710,310|(751,371)|50,000|27,482|



## 



## 

## 

## 

## 

|Group|||||
|---|---|---|---|---|
|||Unrestricted|Restricted|Total Funds|
|||Funds|Funds|2021|
|Tangible fixed assets<br>Current assets||62,085<br>396,373|65,311|127&396<br>396,373|
|Creditors<br>less than<br>1 year<br>Creditors greater than<br>1 year||(30,015)<br>(49,169)||(30,015)<br>(49,169)|
|Net assets||379,274|65,311|444,585|
|Company||Unrestricted<br>Funds|Restricted<br>Funds|Total Funds<br>2021|
|Tangible fixed assets<br>Investments||62,085<br>100|65,311|127,396<br>100|
|Current assets||393,673||393,673|
|Creditors less than<br>1 year<br>Creditors greater than<br>1 year||(27,415)<br>(49,169)||(27,415)<br>(49,169)|
|Net assets||379,274|65,311|444,585|
|Group||Unrestricted<br>Funds|Restricted<br>Funds|Total Funds<br>2020|
|||s|||
|Tangible fixed assets<br>Current assets||50,439<br>73,309|73,474|123,913<br>73,309|
|Creditors<br>less than<br>1year<br>Creditors greater than<br>1 year||(46,230)<br>(50,000)||(46,230)<br>(50,000)|
|Net assets||27,518|73,474|100,992|
|Company||Unrestricted<br>Funds|Restricted<br>Funds|Total Funds<br>2020|
|Tangible fixed assets<br>Investments||50,439<br>100|73,474|123,913<br>100|
|Current assets||71,613||71,613|
|Creditors<br>less than<br>1year<br>Creditors greater than<br>1 year||(44,670)<br>(50,000)||(44,670)<br>(50,000)|
|Net assets||27,482|73,474|100,956|





## 

## 

## 

|||At 1July||At 30June|
|---|---|---|---|---|
|||2020|Cash flows|2021|
|||6||6|
|Cash|in hand and at bank|72,309|323,064|395473|
|Debt|due after one year|(50,000)|831|(49,169)|
|||22409|323,895|346,204|



## 

## 

## 

|SUMMARY OF M|ANCHESTER BRANCH||
|---|---|---|
|||2022|
|Income|||
|Donations<br>Received||320,676|
|~E*<br>Cht|||
|Patient Advice||5,728|
|Medical treatment|costs|96,121|
|Office Costs||17,245|
|Fundraising<br>Costs||63,927|
|Total Expenditure||183,021|



